Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

B32B3 is a cell-permeable, ATP-competitive inhibitor of VprBP that blocks phosphorylation of histone 2A at Thr120 in DU-145 human prostate cancer cells (IC50 = 500 nM).1 It exhibits over 100-fold selectivity for VprBP against a panel of 33 other protein kinases.1 B32B3 strongly suppresses the proliferation of DU-145 cells, which overexpress VprBP, but not MCL normal human prostate cells, which have low levels of VprBP expression.1 At 5 mg/kg twice a week over three weeks, B32B3 inhibits the growth of DU-145 xenograft tumors in mice by 70-75%.1
WARNING This product is not for human or veterinary use.
1. VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription. Mol. Cell 52(3), 459-467 (2013).